Article
Are medullary breast cancers an indication for BRCA1 mutation screening? A mutation analysis of 42 cases of medullary breast cancer.
Breast cancer research and treatment - 1 May 2004
Iau P T C, Marafie M, Ali A, Sng J H, Macmillan R D, Pinder S, Denley H E, Ellis I O, Wenzyck P, Scott N, Cross G, Blamey R W
Abstract excerpt
Recommended guidelines have limited breast cancer gene ( BRCA1 ) mutation testing to individuals with a personal or family history of early onset breast and/or ovarian cancer, and those with multiple affected close relatives. Such large breast cancer families are rare in the general population, limiting the clinical application of the BRCA1 discovery. Previous reports have suggested an association between...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.